These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17516312)

  • 21. [Factors affecting the prognosis and selection of local excision for low rectal cancer].
    Hang JW; Zhou ZX; Bu YQ; Bai XF; Wang X; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):141-3. PubMed ID: 17645854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921.
    den Dulk M; Collette L; van de Velde CJ; Marijnen CA; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bosset JF;
    Eur J Cancer; 2007 Aug; 43(12):1821-8. PubMed ID: 17627809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality indicators of diagnosis and therapy in MRI-based neoadjuvant radiochemotherapy for rectal cancer - interim analysis of a Prospective Multicentre Observational Study (OCUM)].
    Ruppert R; Ptok H; Strassburg J; Maurer CA; Junginger T; Merkel S; Hermanek P
    Zentralbl Chir; 2013 Dec; 138(6):630-5. PubMed ID: 22700247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of rectal cancer].
    Bülow S; Rasmussen PC; Jakobsen AK
    Ugeskr Laeger; 2005 Nov; 167(45):4255-7. PubMed ID: 16277922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer?
    Spiliotis JD; Datsis AC
    J BUON; 2007; 12(1):23-7. PubMed ID: 17436397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy.
    Rosati R; Bona S; Romario UF; Elmore U; Furlan N
    Surg Oncol; 2007 Dec; 16 Suppl 1():S83-9. PubMed ID: 18042378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the surgeon as a variable in the treatment of rectal cancer.
    Hermanek P; Hermanek PJ
    Semin Surg Oncol; 2000 Dec; 19(4):329-35. PubMed ID: 11241915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting anastomotic complications following anterior resection in rectal cancer.
    Lyall A; Mc Adam TK; Townend J; Loudon MA
    Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
    Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
    Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
    Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rectum extirpation or rectum resection in rectal cancer?].
    Herfarth C; Betzler M
    Fortschr Med; 1981 Dec; 99(47-48):1973-6. PubMed ID: 7327490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of rectal cancer: local resection.
    Perretta S; Guerrero V; Garcia-Aguilar J
    Surg Oncol Clin N Am; 2006 Jan; 15(1):67-93. PubMed ID: 16389151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for local recurrence of rectal cancer.
    Heriot AG; Tekkis PP; Darzi A; Mackay J
    Colorectal Dis; 2006 Nov; 8(9):733-47. PubMed ID: 17032318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rectal melanoma: the value of modern treatment].
    Korenkov M; Gönner U; Dünschede F; Junginger T
    Zentralbl Chir; 2008 Dec; 133(6):564-7. PubMed ID: 19090435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer.
    Ptok H; Marusch F; Meyer F; Schubert D; Koeckerling F; Gastinger I; Lippert H;
    Arch Surg; 2007 Jul; 142(7):649-55; discussion 656. PubMed ID: 17638803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.